Orbimed Advisors LLC Protara Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.27 - $3.59 $47,610 - $75,296	-20,974 Reduced 2.64%	772,584 $1.85 Million
Q1 2023 May 15, 2023	SELL	$2.76 - $3.91 $102,349 - $144,994	-37,083 Reduced 4.46%	793,558 $2.48 Million
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.76 $2.34 Million - $2.95 Million	380,641 Added 84.59%	830,641 $5.61 Million
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $7.54 Million - $14.4 Million	450,000 New	450,000 $7.57 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $65.5M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.